Sfoglia per AUTORE
VELTRI E
Collezione AO Ordine Mauriziano

  

Items : 2

Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2022 Apr;71(4):865-874. doi: 10.1007/s00262-021-03045-9. Epub 2021 Aug 31

2022
AO Ordine Mauriziano

Brocco D; Porzio G; Piras M; Rijavec E; Simionato F; Natoli C; Santini D; Vincenzi B; Tonini G; Tiseo M; Marconcini R; Audisio M; Intagliata S; Lai E; Aprile G; Buti S; Ghidini M; Inno A; Macrini S; Di Marino P; Nicolardi L; Tuzi A; Occhipinti MA; Pergolesi F; Veltri E; Filetti M; Adamo V; Ficorella C; Citarella F; et alii...

Germline variants and clinical outcomes of high-risk stage II and stage III colon cancer patients treated with oxaliplatin and fluoropyrimidines adjuvant chemotherapy: A pharmacogenetic ancillary study to TOSCA trial in Annals of Oncology

2017
ASL Biella
AO Ordine Mauriziano

Ruzzo A; Galli F; Rulli E; Lonardi S; Zagonel V; Ronzoni M; Ionta MT; Pella N; Mucciarini C; Labianca R; Veltri E; Sozzi P; Barni S; Nicolini M; Biondi E; Bramati A; Turci D; Buscaglia M; Magnani M; Graziano F; Tampellini M; Falco E; De Rosa G; Montarolo F; Dacomo R; Baratelli C; Sperti E; Di Maio M; Scagliotti GV; et alii...